Australia's Control Bionics jumps on approval for autonomous wheelchair

Control Bionics

20/06/2024 02:31

** Shares of Control Bionics  CBL.AX  jump as much as 60.5%
to A$0.069, their highest level since Sept. 27, 2023
    ** Medical device maker says its autonomous wheelchair
module, DROVE, has been included as a Class 1 Medical Device in
the Australian Register of Therapeutic Goods
    ** With the inclusion, co can commence commercial sales of
the device in Australia - co
    ** About 12 mln shares change hands by 0128 GMT, 66.7 times
the 30-day average volume of shares
    ** Stock down 6.5% this year, as of last close

 (Reporting by Sherin Sunny in Bengaluru)
 ((Sherin.Sunny@thomsonreuters.com))